HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevated serum dopamine-beta-hydroxylase activity in rats with inherited diabetes insipidus.

Abstract
The activity of dopamine-beta-hydroxylase, the enzyme that catalyzes the conversion of dopamine to norepinephrine, was measured in the serum of a strain of Wistar rats homozygous and heterozygous for a genetic form of hypothalamic diabetes insipidus and in Wistar control rats. Serum dopamine-beta-hydroxylase activity and water intake was highest in the homozygous affected rats and lowest in normal controls. Treatment with pitressin tannate reduced serum enzyme activity and water intake in rats with diabetes insipidus to levels which did not differ from controls. Thus serum dopamine-beta-hydroxylase activity appeared to vary directly with changes in sympathetic nerve activity in response to intravascular volume depletion and repletion.
AuthorsG Wooten, T Hanson, F Lamprecht
JournalJournal of neural transmission (J Neural Transm) Vol. 36 Issue 2 Pg. 107-12 ( 1975) Austria
PMID1151368 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Water
  • Vasopressins
  • Dopamine beta-Hydroxylase
Topics
  • Animals
  • Blood Volume
  • Diabetes Insipidus (blood, enzymology, genetics)
  • Dopamine beta-Hydroxylase (blood)
  • Drinking (drug effects)
  • Heterozygote
  • Homozygote
  • Hypothalamus (physiopathology)
  • Male
  • Rats
  • Sympathetic Nervous System (physiology)
  • Vasopressins (pharmacology)
  • Water (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: